Articles tagged "Waiting lists"

2022 American Transplant Congress
Increased Survival Benefit Amongst Highest Priority Candidates Undergoing Heart Transplant Following the New Us Heart Allocation System
S. Tolmie¹, W. Parker²
¹Pritzker School of Medicine, University of Chicago, Chicago, IL, ²Department of Medicine, Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, IL
*Purpose: A key policy change in the new US heart allocation system was splitting the previous highest status (1A) into statuses 1, 2, and 3…
2021 American Transplant Congress
Increasing Survival on the Kidney Transplant Waiting List: A Thirty-Three Year Analysis
E. L. Godfrey¹, P. T. Kambhampati¹, J. A. Goss², A. Rana²
¹Baylor College of Medicine, Houston, TX, ²Division of Abdominal Transplantation, Department of Surgery, Baylor College of Medicine, Houston, TX
*Purpose: The shortage of available donor kidneys remains the greatest obstacle to transplantation, with many patients spending years on the transplant list. During this time,…
2021 American Transplant Congress
Depressive Symptoms and Listing for Kidney Transplantation
X. Chen, N. Chu, P. Sharma Basyal, W. Vihokrut, D. Crews, D. Brennan, S. Andrews, T. Vannorsdall, D. Segev, M. McAdams DeMarco
Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Among patients with kidney failure, depressive symptoms are common and may be a barrier to completing the complex process of kidney transplantation (KT) evaluation…
2021 American Transplant Congress
Influence of Controlled Donation After Circulatory Death (cdcd) on Waiting List Mortalityfor Liver Transplantation in the Last 10 Years: The Spanish Experience
F. Alconchel, M. Royo-Villanova, J. Moya, L. Martínez-Alarcón, J. Zambudio, P. Cascales-Campos, T. Nicolás, R. Robles, F. Sánchez-Bueno, J. Pons, J. Rodríguez, A. Ríos, J. Fernández, P. Ramírez
University Hospital Virgen Arrixaca (IMIB-Arrixaca), Murcia, Spain
*Purpose: Controlled donation after circulatory death (cDCD) provides one third of liver donors in Spain nowadays. The aim of our work is to evaluate the…
2021 American Transplant Congress
Outcomes of Covid 19 in Candidates Waitlisted for Kidney and Pancreas Transplantation
R. El-Rifai¹, S. Riad¹, R. Belina², A. Matas²
¹Medicine, University of Minnesota, Minneapolis, MN, ²Surgery, University of Minnesota, Minneapolis, MN
*Purpose: The COVID 19 pandemic has posed new challenges to transplant centers. The impact has been detrimental on wait-listed ESKD patients, reducing their access to…
2021 American Transplant Congress
The Evolution of the National Liver Review Board
S. Noreen¹, J. Trotter², J. Pomposelli³, M. Cafarella¹, J. Heimbach⁴
¹UNOS, Richmond, VA, ²BSWHealth, Dallas, TX, ³UCHealth, Aurora, CO, ⁴Mayo Clinic, Rochester, MN
*Purpose: The National Liver Review Board (NLRB) was implemented 5/14/2019, establishing a national structure for liver exceptions comprised of three specialty review boards and a…
2021 American Transplant Congress
Launching a National Living Donor Registry
J. E. Milton¹, M. Cooper², B. Hippen³
¹Transplant Center, University of Texas Health San Antonio, San Antonio, TX, ²MedStar Georgetown Transplant Institute, Washington, Colombia, ³Metrolina Nephrology Associates, PA, Charlotte, NC
*Purpose: The National Donate Life Living Donor Registry launching in 2021 will allow 4000 persons a day the opportunity to become a living donor offering…
2021 American Transplant Congress
Short Waiting Time is Not Associated with Decrease in Disease-free Survival in Liver Transplant Recipients with HCC
J. Daum¹, N. Gupta¹, B. Aqel², L. Mi³, J. Harbell⁴
¹School of Medicine, Mayo Clinic Arizona, Phoenix, AZ, ²Hepatology, Mayo Clinic Arizona, Phoenix, AZ, ³Biostatistics, Mayo Clinic Arizona, Phoenix, AZ, ⁴Transplant Surgery, Mayo Clinic Arizona, Phoenix, AZ
*Purpose: Studies have suggested that shorter waiting times (WT) for liver transplant (LT) in patients with hepatocellular carcinoma (HCC) may be associated with increased HCC…
2021 American Transplant Congress
One-Year Monitoring of Changes to Kidney-Pancreas Waiting Time Criteria: An OPTN Analysis
R. C. Forbes¹, B. Plucinski², J. White², N. T. Kyaw², R. Kandaswamy³, S. V. Niederhaus⁴
¹Surgery, Vanderbilt University, Nashville, TN, ²UNOS, Richmond, VA, ³Surgery, University of Minnesota, Minneapolis, MN, ⁴Surgery, University of Maryland, Baltimore, MD
*Purpose: In 2018, the OPTN board approved changes to kidney-pancreas (KP) waiting time criteria. KP candidates accrued waiting time if they were (1) on insulin…
2021 American Transplant Congress
Additional Value to Participation in a National Paired Kidney Exchange Program: Exploring Characteristics of Chain End Living Donors and Waitlist Recipients
N. Osbun¹, A. Thomas², M. Cooper³, S. Flechner⁴, D. Segev², J. Veale¹
¹Urology, University of California Los Angeles, Los Angeles, CA, ²Johns Hopkins University, Baltimore, MD, ³Medstar Georgetown Transplant Institute, Washington DC, DC, ⁴Cleveland Clinic, Cleveland, OH
*Purpose: Non-directed kidney donors can initiate living donor chains that end to patients on the deceased donor waitlist. While many studies of paired exchange practices…

« Previous Page
1
…
4
5
6
7
8
…
44
Next Page »